Leaflet: Information for the user
Amlodipine/Valsartan Macleods 10 mg/160 mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
5 Conservation of Amlodipine/Valsartan Macleods
Amlodipine/Valsartan Macleods tablets contain two substances called amlodipine and valsartan. Both substances help control high blood pressure.
This means that both substances help prevent the narrowing of blood vessels. As a result, blood vessels relax and blood pressure decreases.
Amlodipine/Valsartan Macleods is used to treat high blood pressure in adults whose blood pressure is not adequately controlled with amlodipine or valsartan alone.
Do not take Amlodipine/Valsartan Macleods
If you are pregnant for more than 3 months. (It is also best to avoid taking Amlodipine/Valsartan Macleods at the start of your pregnancy, see the Pregnancy section).
Do not take Amlodipine/Valsartan Macleods and inform your doctor if you are affected by any of the above cases.
Warnings and precautions
Consult your doctor before starting to take Amlodipine/Valsartan Macleods:
Your doctor may check your kidney function, blood pressure, and electrolyte levels (e.g., potassium) in your blood at regular intervals.
See also the information under the heading "Do not take Amlodipine/Valsartan Macleods".
Tell your doctor before taking Amlodipine/Valsartan Macleods if you are affected by any of the cases mentioned.
Children and adolescents
The use of Amlodipine/Valsartan Macleods is not recommended in children or adolescents (under 18 years of age).
Other medications and Amlodipine/Valsartan Macleods
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to use any other medication. Your doctor may need to modify your dose and/or take other precautions. In some cases, you may need to stop taking one of the medications. This is especially applicable to the medications listed below:
agentes anticonvulsivos (p. ej. carbamacepina, fenobarbital, fenitoína, fosfenitoína, primidona);
Taking Amlodipine/Valsartan Macleods with food and drinks
People taking Amlodipine/Valsartan Macleods should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice can lead to an increase in the levels of the active ingredient amlodipine in the blood, which can cause an unpredictable increase in the blood pressure-lowering effects of Amlodipine/Valsartan Macleods.
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant or think you may be pregnant. Your doctor will usually advise you to stop taking Amlodipine/Valsartan Macleods before becoming pregnant or as soon as you become pregnant, and recommend taking another medication instead of Amlodipine/Valsartan Macleods. Amlodipine/Valsartan Macleods is not recommended during the first 3 months of pregnancy and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby.
Breastfeeding
If you are breastfeeding or about to start breastfeeding, you should inform your doctor. It has been shown that amlodipine passes into breast milk in small amounts.
Amlodipine/Valsartan Macleods is not recommended for breastfeeding mothers, and your doctor may decide to prescribe a different treatment that is more suitable if you want to breastfeed, especially for newborns or premature babies.
Consult your doctor or pharmacist before using any medication.
Driving and using machines
This medication may make you feel dizzy. This can affect your ability to concentrate. If you are unsure how this medication will affect you, do not drive, use machines, or perform other activities that require concentration.
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor again. This will help you get the best results and reduce the risk of side effects.
The normal dose of Amlodipine/Valsartan Macleods is one tablet per day.
Depending on your response to treatment, your doctor may suggest a higher or lower dose.
Do not exceed the prescribed dose.
Amlodipine/Valsartan Macleods and elderly people (65 years or older)
Your doctor should exercise caution when increasing your dose.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
If you take more Amlodipine/Valsartan Macleods than you should
If you have taken too many Amlodipine/Valsartan Macleods tablets, or if someone else has taken your tablets, consult a doctor immediately.
Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing, which can develop up to 24-48 hours after ingestion.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Amlodipine/Valsartan Macleods
If you forget to take this medication, take it as soon as you remember. Then take the next dose at the usual time. However, if it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for missed doses.
If you stop taking Amlodipine/Valsartan Macleods
Stopping your treatment with Amlodipine/Valsartan Macleods may cause your condition to worsen. Do not stop taking your medication unless your doctor tells you to.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Some side effects can be serious and require immediate medical attention.A few patients have experienced these serious side effects (may affect up to 1 in 1,000 patients).If you notice any of the following, inform your doctor immediately:
Allergic reaction with symptoms such as skin rash, itching, swelling of the face, lips, or tongue, difficulty breathing, low blood pressure (feeling of fainting, dizziness).
Other possible side effects of Amlodipine/Valsartan Macleods:
Common(may affect up to 1 in 10 people): Flu; stuffy nose, sore throat, and discomfort when swallowing; headache; swelling in the arms, hands, legs, ankles, or feet; fatigue; asthenia (weakness); flushing and warming of the face and/or neck.
Uncommon(may affect up to 1 in 100 people): Dizziness; nausea and abdominal pain; dry mouth; drowsiness, tingling, or numbness of the hands or feet; vertigo; rapid heartbeat, including palpitations; dizziness when standing up; cough; diarrhea; constipation; skin rash, redness of the skin; joint inflammation, back pain; joint pain.
Rare(may affect up to 1 in 1,000 people): Feeling of anxiety; ringing in the ears (tinnitus); fainting; increased urine production or urgent need to urinate; inability to achieve or maintain an erection; feeling of heaviness; low blood pressure with symptoms such as dizziness, lightheadedness; excessive sweating; skin rash all over the body, itching, muscle spasms. Inform your doctor if you are severely affected by any of the cases mentioned.
Side effects reported with amlodipine or valsartan alone and not observed with Amlodipine/Valsartan Macleods or observed with a higher frequency than with Amlodipine/Valsartan Macleods:
Amlodipine
Consult your doctor immediately if you experience any of the following serious side effects, which are very rare after taking this medication:
The following side effects have been reported. If any of these cause problems or last more than a week, consult your doctor:
Common(may affect up to 1 in 10 people): Dizziness, drowsiness; palpitations (feeling the heartbeat); flushing, swelling of the ankles (edema); abdominal pain, feeling of discomfort (nausea).
Uncommon(may affect up to 1 in 100 people): Mood changes, anxiety, depression, drowsiness, tremors, taste disturbances, fainting, loss of pain sensation; visual disturbances, visual impairment, ringing in the ears; low blood pressure; runny nose/nasal secretion caused by inflammation of the nasal mucosa (rhinitis); indigestion, vomiting (discomfort); hair loss, increased sweating, itching, skin discoloration; urinary disorders, increased need to urinate at night, increased frequency of urination; inability to achieve an erection, discomfort or breast enlargement in men, pain, feeling of discomfort, muscle pain, muscle cramps; weight gain or weight loss.
Rare(may affect up to 1 in 1,000 people): Confusion.
Very rare(may affect up to 1 in 10,000 people): Decreased white blood cell count, decreased platelet count in the blood that can cause easy bleeding or unusual bruising (red blood cell damage); high blood sugar (hyperglycemia); gum inflammation, abdominal swelling (gastritis); abnormal liver function, liver inflammation (hepatitis), yellowing of the skin (jaundice), increased liver enzymes that can affect some medical tests; increased muscle tension; blood vessel inflammation often with skin rashes, sensitivity to light; disorders combining stiffness, tremors, and/or movement disorders.
Valsartán
Frequency not known(frequency cannot be estimated from available data): Decreased red blood cell count, fever, sore throat, or mouth ulcers due to infection; spontaneous bleeding or bruising; high potassium levels in the blood; abnormal liver function test results; decreased kidney function and severely decreased kidney function; swelling, mainly of the face and throat; muscle pain; skin rash, purplish red spots; fever; itching; allergic reaction, blistering skin disease (sign of a disease called bullous dermatitis).
If you experience any of the cases mentioned, consult your doctor immediately.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 30°C
Do not use any Amlodipine/Valsartan Macleods packaging that is damaged or shows signs of tampering.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofAmlodipine/Valsartan Macleods.
Appearance of the Product and Packaging Content
Film-coated tablets of soft yellow color, oval, biconvex, marked with "C95" on one side and smooth on the other.
The following formats are available: boxes with blisters of 14, 28, 30, 56, 90, and 98 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Macleods Pharma España S.L.U.
World Trade Center Barcelona,
Moll de Barcelona, s/n,
08039 Barcelona,
Spain
Manufacturer
Synoptis Industrial Sp. z o.o.
ul. Rabowicka 15
62-020 Swarzedz, Poland
Or
Heumann Pharma GmbH & Co. Generica KG,
Südwestpark 50,
90449 Nürnberg, Germany
Or
Accord Healthcare B.V.
Winthontlaan 200, 3526 KV Utrecht, Netherlands
Or
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50, 95-200 Pabianice, Poland
Date of the last revision of this leaflet: March 2023
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of AMLODIPINE/VALSARTAN MACLEODS 10 mg/160 mg FILM-COATED TABLETS in October, 2025 is around 13.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.